Screening for colorectal cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 9628952.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Randomized, controlled trials have shown with certainty that screening for colorectal cancer reduces morbidity and is cost-effective. Factors that increase the risk of colorectal cancer include a personal or family history of adenomatous polyps or colorectal cancer, certain genetic syndromes and chronic inflammatory bowel disease.
Medical subject headings
- Colorectal Neoplasms
- Mass Screening